|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.24 EUR | -1.00% |
|
-2.48% | -20.24% |
| 05-11 | DANONE : Barclays gives a Buy rating | ZD |
| 05-05 | Weight-loss drugs fuel protein-rich whey craving | RE |
Company Valuation: Danone
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 35,530 | 30,830 | 37,646 | 41,915 | 49,156 | 39,204 | - | - |
| Change | - | -13.23% | 22.11% | 11.34% | 17.28% | -20.25% | - | - |
| Enterprise Value (EV) 1 | 46,030 | 40,937 | 47,867 | 50,516 | 57,587 | 46,978 | 46,045 | 45,277 |
| Change | - | -11.06% | 16.93% | 5.53% | 14% | -18.42% | -1.99% | -1.67% |
| P/E ratio | 18.6x | 33.3x | 45.1x | 20.8x | 27.2x | 16.2x | 15x | 14x |
| PBR | 2.02x | 1.76x | 2.33x | 2.59x | 2.93x | 2.17x | 2.05x | 1.91x |
| PEG | - | -0.7x | -3.7x | 0x | -2.75x | 0.5x | 1.83x | 1.87x |
| Capitalization / Revenue | 1.46x | 1.11x | 1.36x | 1.53x | 1.8x | 1.4x | 1.35x | 1.29x |
| EV / Revenue | 1.9x | 1.48x | 1.73x | 1.85x | 2.11x | 1.67x | 1.58x | 1.49x |
| EV / EBITDA | 10x | 7.81x | 9.4x | 10.7x | 11.5x | 9.46x | 8.81x | 8.21x |
| EV / EBIT | 13.8x | 12.1x | 13.8x | 14.2x | 15.7x | 12.3x | 11.3x | 10.6x |
| EV / FCF | 18.9x | 19.6x | 18.2x | 16.8x | 20.6x | 17.1x | 16.6x | 15.1x |
| FCF Yield | 5.28% | 5.11% | 5.5% | 5.94% | 4.86% | 5.85% | 6.04% | 6.63% |
| Dividend per Share 2 | 1.94 | 2 | 2.1 | 2.15 | 2.25 | 2.339 | 2.492 | 2.653 |
| Rate of return | 3.55% | 4.06% | 3.58% | 3.3% | 2.93% | 3.82% | 4.07% | 4.33% |
| EPS 2 | 2.94 | 1.48 | 1.3 | 3.13 | 2.82 | 3.77 | 4.079 | 4.385 |
| Distribution rate | 66% | 135% | 162% | 68.7% | 79.8% | 62% | 61.1% | 60.5% |
| Net sales 1 | 24,281 | 27,661 | 27,619 | 27,376 | 27,283 | 28,050 | 29,122 | 30,304 |
| EBITDA 1 | 4,602 | 5,240 | 5,092 | 4,726 | 5,020 | 4,965 | 5,227 | 5,515 |
| EBIT 1 | 3,337 | 3,377 | 3,481 | 3,558 | 3,665 | 3,824 | 4,061 | 4,289 |
| Net income 1 | 1,924 | 959 | 881 | 2,021 | 1,825 | 2,389 | 2,572 | 2,774 |
| Net Debt 1 | 10,500 | 10,107 | 10,221 | 8,601 | 8,431 | 7,774 | 6,840 | 6,073 |
| Reference price 2 | 54.59 | 49.23 | 58.68 | 65.12 | 76.78 | 61.24 | 61.24 | 61.24 |
| Nbr of stocks (in thousands) | 650,849 | 626,246 | 641,543 | 643,653 | 640,218 | 640,173 | - | - |
| Announcement Date | 23/02/22 | 22/02/23 | 22/02/24 | 26/02/25 | 20/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.24x | 1.67x | 9.46x | 3.82% | 45.56B | ||
| 19.43x | 2.83x | 13.92x | 4.02% | 255B | ||
| 21.41x | 2.45x | 14.38x | 3.42% | 77.58B | ||
| 17.68x | 0.54x | 10.47x | 2.58% | 38.75B | ||
| 23.37x | 3.43x | 13.97x | 3.08% | 37.93B | ||
| 39.33x | 3.4x | 18.98x | 0.9% | 31.77B | ||
| 83.58x | 12.15x | 54.27x | 0.98% | 28.75B | ||
| 10.91x | 1.82x | 8.98x | 7% | 27.18B | ||
| 14.07x | 0.4x | 9.2x | 2.33% | 23.76B | ||
| 34.41x | 0.7x | 17.61x | 0.73% | 21.97B | ||
| Average | 28.04x | 2.94x | 17.12x | 2.89% | 58.85B | |
| Weighted average by Cap. | 23.74x | 2.84x | 15.37x | 3.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BN Stock
- Valuation Danone
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















